Trial
NCT04298983
Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alabama at Birmingham
Collaborators
Eli Lilly and Company
Condition
Prostate Cancer
Intervention
Abemaciclib 150 MG by mouth twice daily
Why stopped
Abemaciclib efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-19